How to diagnose and treat male infertility in 2011 Roelof Menkveld, PhD Andrology Laboratory, Department of Obstetrics and Gynaecology, Tygerberg Academic.

Slides:



Advertisements
Similar presentations
Role of Micronutrients in the Management of Male Infertility
Advertisements

INFERTILITY – AN OVERVIEW
Re-evaluation of sperm morphology assessment and results in light of new WHO (2010) manual reference limits Roelof Menkveld, PhD Andrology Laboratory,
Specialist in Reproductive Surgery &
Andrology and IVF Laboratory Services
What We Do and Why We Do It Our Bundles Of Joy.
POSTER TEMPLATE BY: Molecular and Cellular Characterization of Normal Versus Aberrant Sperm from Fertility Test Groups Sayed.
Environment and fertility: Male-mediated factors Shanna H. Swan, PhD Professor Obstetrics & Gynecology University of Rochester School of Medicine.
İstanbul Memorial Hospital ART and Genetics Center Section 2.
May 18, 2015 NURS 330 Human Reproductive Health. Agenda Review 5/4/15 In-Class Assignment Review Quiz Infertility Lecture Submission of Group Project.
Introduction to the Male Half of Reproductive Biology Genevieve Griffiths University Of Delaware.
Is IVF the only Solution to Age Related Infertility Problem? By Suzis Zeus 1
Thanks to new medical technology- in vitro fertilization treatment which has brought hope to couples who have been unable to conceive naturally despite.
Infertility 101 Dana Ambler, DO Director, Donor Egg Program Associate Physician Conceptions Reproductive Associates.
Analysis of Sperm– the number game
Fertility issues for patients with lymphoma
Infertility To have a baby…. Infertility refers to the inability of a couple to conceive after 1 year of ‘trying’ It is estimated that 1 in 6 couples.
REPRODUCTIVE FUNCTIONS OF THE AGEING MALE
Bio 27 November 7, 2012 Chapter 11: Conception, Pregnancy, and Childbirth.
What is Assisted Reproduction Technology? Jessica Guerrero.
Infertility Parenting. What is Infertility? n Not being able to get pregnant after at least one year of trying. n Women who are able to get pregnant but.
Fellowship in Andrology and Men’s Health Andrology & Men’s Health is a field of medicine which deals with the problems related to male health, male infertility.
In vitro fertilisation (I.V.F)
More Than 60 Published Studies In Medical Literature SMOKING & REPRODUCTION.
1 Maternal Shift Work and the Risk of Urogenital Defects in Offspring Conceived Using Infertility Treatment Fertility Society Australia Conference 2015,
Assisted Reproductive Techniques (ART) Biological Science
Male & Female Investigations Workup Routine / Prior to IVF
The Effects of NOS Isoforms In Human Normospermia, Asthenospermia And Oligospermia Cases H. Karakaya 1, E. Ünsal 1, A. Kandil 2, Y. E. Canıllıoğlu 1, C.
The 4th Misurata scientific meeting of infertility Benghazi – Libya 10/10/2008 Dr. Omar A. Elsraiti Consultant of Obst. & Gyn. IVF Centre - Misurata /
TEMPLATE DESIGN © IMPACT OF SEXUAL ABSTINENCE DURATION ON ICSI OUTCOME May Kew Loke and Pak Seng Wong Sunfert International.
Semen analysis WHO ys 5 th edition: 2010 Lower reference limits (5th centiles and their 95% confidence intervals) Pregnancy during 12m Other groups.
Selecting sperm for ICSI - IMSI Allan Pacey University of Sheffield Sheffield Teaching Hospitals.
Infertility. Fertility Sub fertility Sterility Infertility:Diminished capacity to conceive and bear a child Sterility:Absolute and irreversible inability.
1 INFERTILITY 1. Definitions Under 35 yoNo conception after one year of unprotected intercourse Over 35 yoNo conception after 6 months of unprotected.
VARICOCELE  Most common identifiable pathology in infertile men.  Affects 35% - 40% of men presenting for infertility evaluation.
Solutions to Infertility Reproductive Technologies.
The role of IMSI in sperm selection
Problems with the In Vitro Fertilisation Treatment of Heterosexual Couples Health Law and Bioethics Georgi Avramov, Student Number: , Erasmus + Student.
EMF and Reproductive Health Risks Ashok Agarwal Professor, Lerner College of Medicine Director, Center for Reproductive Medicine Director, Andrology Laboratory.
Sperm DNA fragmentation testing as a general marker for pregnancy outcome in IVF patients. Marron K, Harrity C, Walsh D, Walsh APH. Sims IVF Clinic, Dublin.
Synthesis of Sperm &Seminal Plasma Sperm Production Maturation &Storage Seminal Plasma Semen Testes: Sertoli Cells Epididymis & Vas Deference Epididymis.
Endometrial biopsy in subfertile women undergoing intrauterine insemination (IUI) cycles improves pregnancy rates Tumanyan A, Tchzmachyan R, Grigoryan.
Ast Prof. University of Washington
Semen analysis Lecture 5 Dr. Khalid Mohammed Karam
INTRODUCTION Use 1 slide
A study on the differences in general parameters and DNA integrity of spermatozoa of smokers and non-smokers Diganta Dey1, Abhijit Banerjee1, Sugat Sanyal1,
Metabolomics Study of Human Seminal Plasma of Infertile Men
Reproductive Health Nursing NUR 324
Assisted reproduction and obstetrics
Infertility Parenting.
Dr. Farhat R Malik Associate Professor Community Health Sciences- PMC
Infertility Clinics in Hyderabad Sridevi Fertility Centre Sridevi Fertility Center is among the pioneers to introduce the advanced technologies in the.
The sperm acrosome reaction response to progesterone associated with sperm DNA damage has a better predicting value for IVF than that response to the ionophore.
Fertility Assessment & Treatment
Ashok Agarwal, Ph. D. , H. C. L. D. , Rakesh Sharma, Ph. D
Methods Objectives Results Conclusions References References
מערכת הרבייה הזכרית.
THE SPERM ACROSOME REACTION RESPONSE TO PROGESTERONE ASSOCIATED WITH SPERM DNA DAMAGE HAS A BETTER PREDICTING VALUE FOR IVF THAN THAT RESPONSE TO THE IONOPHORE.
Developmental sperm contributions: fertilization and beyond
Diagnostic application of oxidation-reduction potential assay for measurement of oxidative stress: clinical utility in male factor infertility  Ashok.
Ultrastructural findings in semen samples of infertile men infected with Chlamydia trachomatis and mycoplasmas  Guadalupe Gallegos-Avila, M.D., Marta.
Impact of sperm morphology on DNA damage caused by oxidative stress induced by β- nicotinamide adenine dinucleotide phosphate  Tamer M. Said, M.D., Ashok.
BSE II RAM / BUCK S. ‘Tona Olurode Theriogenology Unit
Common Queries In Infertility
Improving ART OUTCOME:Looking beyond SFA in male factor infetility
Male Factor Infertility. Male factor infertility is a complex problem and requires the expertise of specially-trained professionals who stay abreast of.
Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D. 
How reliable are results from the semen analysis?
The functionality of mitochondria differentiates human spermatozoa with high and low fertilizing capability  Frédérique Gallon, M.D., Carole Marchetti,
Presentation transcript:

How to diagnose and treat male infertility in 2011 Roelof Menkveld, PhD Andrology Laboratory, Department of Obstetrics and Gynaecology, Tygerberg Academic Hospital and University of Stellenbosch. III rd Congress of the Society of Reproductive Medicine Cornelia Diamond Resort Belek, Antalya, Turkey 05 to 09 October 2011

Lecture objectives Give an overview of the evolution of the (normal) semen parameter values of the different WHO manual editions from 1980 to 2010 (WHO-5) Discuss the usefulness of the new semen parameter values with special reference to normal sperm morphology of WHO-5 Discuss some treatment options in cases where men present with poor semen analysis results

Old manuals Old wording in previous manuals –1st edition No specific wording or definitions for semen parameter values ( Used normal and fertile range) –2nd and 3rd editions Used term “normal” values –4th edition uses term “reference” values Statement –The (mean?) normal “reference” values quoted in these manuals are for “normal” men and NOT the MINIMUM requirements for fertilisation

New wording for definition of “normal” values in 5th WHO manual edition New wording for “normal of reference” values –Refer to Lower reference limits Reference ranges

Material and methods for WHO-5 edition (1) Reference population –Fathers (Couples with time to pregnancies of ≤ 12 months) –1600+ couples –Five centres from 3 continents Samples –Only 1 sample per father –Complete sample after 3-7 days of abstinence WHO manual, 2010

Material and methods for WHO-5 edition (2) Methods –Only laboratories following WHO manual guidelines Sperm concentration by haemocytometer only –Sperm morphology evaluation according to STRICT CRITERIA only Statistics –Reference values based on the lower 5th percentile limits WHO manual, 2010

Normal values for WHO manuals, editions 2- 4 and expected lower reference limits and WHO- 5 manual Semen parameter WHO edition and year 2nd rd th th Volume (ml) Sperm concentration (10 6 /ml)20 15 Total sperm count (10 6 )40 39 Motility (% progressive)50 28 Vitality (% live) Morphology (% normal)5030(15) 4

Recent studies proposing new “cut-off, normal or reference” values Three types of literature studies –Based on In vivo or in vitro pregnancies Fertile versus subfertile populations Lower interval values

Lower percentile intervals Ombelet et al., Lower 10th percentile Menkveld et al., Lower 10th percentile Haugen et al., Lower 10th and 5th percentile

Comparison of expected new WHO manual lower reference values and recent published values Semen parameter Publication Menkveld et al., 2001 * Haugen et al., th WHO manual 5th10th Sperm concentration (10 6 /ml) N/A Motility (% progressive) Morphology (% normal) 3344 * Adjusted ROC curve values

Comments on the lower reference values of WHO-5 manual Has lead to more confusion especially with clinicians Need a more “precise or detailed” breakdown of semen parameter values Need a new approach to interpretation of normal sperm morphology values

Need for a more “precise or detailed” breakdown of semen parameter values Use of categories or intervals

Classification of male fertility potential according to semen parameters as used at Tygerberg Hospital Semen parameter Fertility potential classification InfertileSubfertileFertile Concentration (10 6 /ml)< – 9.9≥ 10.0 Motility (% progressive)< 1010 – 29≥ 30 Morphology (% normal)< ≥ 15 Semen volume (ml)< 1.0> – 6.0 Fertile or Normal = Optimal chance for pregnancy Subfertile or Borderline = Reduced chance for pregnancy Infertile or Pathological = Small change for pregnancy Menkveld, 2007

Need for a new approach for the interpretation of normal sperm morphology values

Sperm morphology Values as determined by strict (Tygerberg) criteria (Menkveld et al., 1990) and according to the old editions of WHO manuals are not applicable anymore due to decrease in normal sperm morphology values over years New approach for interpretation of sperm morphology parameters is needed Menkveld et al., 1990

Overview of declining sperm morphology values over years Menkveld etal., 1986; Menkveld, 2010

Prognostic sperm morphology groups Currently used based on strict criteria (Menkveld et al., 1990) Normal –≥ 15% morphological normal spermatozoa Good prognosis group –5 to 14% morphological normal spermatozoa Poor prognosis group –≤ 4% morphological normal spermatozoa WHO-5 lower (Normal) reference value –≥ 4% morphological normal spermatozoa Menkveld et al., 1990; Kruger et al., 1986; Kruger et al., 1988; WHO, 2010

Declining normal sperm morphology values Decline due to three possible reasons –Stricter application of evaluation criteria –Negative environmental influences –Additional parameters for sperm morphology abnormalities

Stricter application of sperm morphology evaluation criteria Introduction of STRICT CRITERIA –Strict versus liberal approach Chanced from borderline spermatozoa previous regarded as normal to TOO BE REGARDED AS ABNORMAL –Over critical approach for interpretation of normal –Inadequate training

Negative environmental influences Exposure to pseudo-estrogens of mother, unborn baby and male –Higher incidences of decrease in male reproductive health Higher exposure to toxic environment and occupation hasards –Decrease in spermatogenesis and lower/poorer semen parameters Higher incidences of sexual transmitted diseases –Lower semen parameters –Increase of leukocytospermia –Increased sperm DNA damage

Decline due to introduction of additional parameters for sperm morphology abnormalities For example –Differential classification of acrosome morphology Normal Staining defects Too large Too small Other/Amorphous

New approach for interpretation of sperm morphology parameters is needed Better use of existing sperm morphology parameters Better quality control Use of additional sperm morphology parameter, especially in patients with teratozoospermia according new lower reference value of ≤ 3% (Poor prognosis group)

Better use of existing sperm morphology parameters Acrosome morphology (Acrosome index) –TZI –Cytoplasmic residues –Semen cytology Identification, reporting and treatment of WBC on semen smears

Better quality control for sperm morphology evaluation Problem Lack of intra- and inter-laboratory quality control Lack off standardisation between different international QC schemes Solutions Betters adherence to WHO guidelines (aim of new WHO manual) Better co-operation between and standardisation of the different international QC schemes

Use of additional sperm morphology parameters In WHO abnormal morphology group (≤ 3%) Identification of abnormal sperm morphology patterns –Abnormal acrosome staining –Large sperm/acrosome patterns –Small sperm/acrosome patterns –Elongated sperm morphology patterns

Large acrosomes – Spermac stain Spontaneous acrosome reaction No zona pellucida binding of spermatozoa

Small acrosomes Mostly non-viable Can not undergo acrosome reaction Can not bind to zona pellucida

Acrosome reacted – Papanicolaou staining Not able to bind to the zona pellucida

Acrosome reacted – Spermac stain

Acrosomes with staining defects Beginning of acrosome reaction ? Cysts and vacuoles ? Membrane damage ? Not able to bind to zona pellucida ? DNA status (MSOME) ?

Large headed spermatozoa DNA status ? Poor prognosis for normal in vitro fertilisation

Elongated spermatozoa pattern DNA damage Ultrastructural nuclear defects Stress Chromosome aneuploidy (Prisant et al., 2007)

Neck defects Absence of centriole – no spindle formation in oocyte Midpiece abnormalities Mitochondrial defects (? Poor motility)

Cytoplasmic residues ROS production Immaturity of spermatozoa

Theoretical treatment option ( Male fertile) Semen parameter Fertility potential classification InfertileSubfertileFertile Concentration (10 6 /ml)< – 9.9≥ 10.0 Motility (% progressive)< 1010 – 29≥ 30 Morphology (% normal)?? ≤ 3 ≥ 4 Semen volume (ml)< 1.0> – 6.0 Treatment will depend on several factors Age of couple – ART for older women Years of infertility – If woman is “normal” give time If female factor treat with ART

Theoretical treatment option ( Male subfertile) Semen parameter Fertility potential classification InfertileSubfertileFertile Concentration (10 6 /ml)< – 9.9≥ 10.0 Motility (% progressive)< 1010 – 29≥ 30 Morphology (% normal)≤ 3???? ≤ 3#≥ 4 Semen volume (ml)< 1.0> – 6.0 ?? ≤ 3# - No apparent abnormal sperm morphology pattern Treatment will depend on several factors Age of couple – ART for older women (IUI, IVF) Years of infertility – If woman is “normal” give limited time If female factor - treat with ART (IVF, ICSI)

Theoretical treatment option ( Male infertile) Semen parameter Fertility potential classification InfertileSubfertileFertile Concentration (10 6 /ml)< – 9.9≥ 10.0 Motility (% progressive)< 1010 – 29≥ 30 Morphology (% normal)?? ≤ 3 ≥ 4 Semen volume (ml)< 1.0> – 6.0 ?? ≤ 3# - IF apparent abnormal sperm morphology pattern Treatment = ICSI ??

Tygerberg Academic Hospital and University of Stellenbosch Medical School, Tygerberg (Cape Town), South Africa Thank you for your attention

References Haugen et al., Int J Androl 27:66-71,2006 Kruger et al., Fertil Steril 46: ,1986 Kruger et al., Fertil Steril 49:112-7,1988 Menkveld R. In: Male infertility – Diagnosis and treatment. Oehninger and Kruger (eds). Informa Healthcare, 2007 Menkveld et al., Human Reprod 5(5):586-92,1990 Menkveld R. Asian J Androl 12(1):47-58,2010 Menkveld et al., Arch Androl 17:143-4,1986 Menkveld et al., Hum Reprod 16: ,2001 Ombelet et al., Hum Reprod 12:987-93,1997 World Health Organisation. WHO laboratory manual for the examination and processing of human semen. WHO Press, Geneva. 2010